Kitasamycin

Kitasamycin is an antibiotic belonging to the macrolide class, which is used primarily in veterinary medicine. It is produced by the bacterium Streptomyces kitasatoensis. Kitasamycin is utilized for its antimicrobial properties to treat bacterial infections in animals. It works by inhibiting protein synthesis in bacteria, thereby stopping their growth and multiplication.
Uses[edit]
Kitasamycin is mainly used in the treatment and prevention of bacterial infections in livestock and poultry. It is effective against a variety of Gram-positive bacteria and some Gram-negative bacteria. The antibiotic is often administered in feed or water for animals, including pigs, chickens, and turkeys, to control and treat respiratory and enteric infections.
Mechanism of Action[edit]
The mechanism of action of kitasamycin involves the inhibition of bacterial protein synthesis. It binds to the 50S ribosomal subunit of the bacteria, preventing the translocation of peptides during translation, which is a critical step in protein synthesis. This action is similar to that of other macrolide antibiotics, leading to the suppression of bacterial growth and proliferation.
Resistance[edit]
As with many antibiotics, the use of kitasamycin can lead to the development of antibiotic resistance. Bacteria may develop resistance mechanisms, such as modifying the target site of the antibiotic, reducing drug accumulation, or hydrolyzing the drug. The prudent use of kitasamycin, along with the implementation of antibiotic stewardship programs, is essential to minimize the development of resistance.
Side Effects[edit]
The use of kitasamycin in animals can lead to some side effects, although these are generally mild and transient. Possible side effects include gastrointestinal disturbances, such as diarrhea and vomiting, and changes in the microbial flora of the intestine. It is important to follow the prescribed dosage and administration guidelines to minimize the risk of side effects.
Regulation[edit]
The use of kitasamycin in food-producing animals is subject to regulation and oversight by veterinary and food safety authorities in various countries. Regulations may include maximum residue limits (MRLs) in food products derived from treated animals to ensure food safety for human consumption. Compliance with these regulations is crucial to maintain the efficacy of antibiotics and to protect public health.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
